Companies in #COPD
Found 3 companies operating in this sector.
Expedition Therapeutics
PrivateBiotech developing disease-controlling treatments for COPD and other neutrophil-driven inflammatory respiratory diseases. Lead candidate EXPD-101 is an oral, once-daily DPP1 inhibitor advancing into a global Phase 2 COPD trial. Backed by Sanofi.
SMSbiotech
PrivateClinical-stage regenerative medicine company developing an allogeneic, off-the-shelf Small Mobile Stem (SMS) cell platform derived from adult blood, led by an inhaled SMS cell therapy program for COPD.
Theravance Biopharma is a specialty biopharmaceutical company focused on respiratory diseases, commercializing YUPELRI (revefenacin) for COPD through a Viatris partnership, with a research pipeline targeting lung disease.